Timothy Hardy
Impact in
- Hepatology top 0.2%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Disease and Transplantation 3
- Liver physiology and pathology 3
- Aging 1
- Co-authors
- Quentin M. AnsteeElisabetta BugianesiJacob GeorgeMohammed EslamZobair M. YounossiLinda HenryM. MariettiChristopher P. Day
- Journals
- Journal of Hepatology (4 papers)Clinical Gastroenterology and Hepatology (3 papers)Clinical Epigenetics (2 papers)Gut (2 papers)Nature Medicine (1 paper)
- Partner nations
- United KingdomAustraliaTürkiye
In The Last Decade
Timothy Hardy
23 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Hepatology 2.5k
- Epidemiology 5.8k
- Endocrinology, Diabetes and Metabolism 2.4k
- Aging 134
- Physiology 1.3k
Countries citing papers authored by Timothy Hardy
This map shows the geographic impact of Timothy Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Hardy more than expected).
Fields of papers citing papers by Timothy Hardy
This network shows the impact of papers produced by Timothy Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Hardy. The network helps show where Timothy Hardy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy Hardy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2020 | 9 | |
| 3 | 2019 | 60 | |
| 4 | 2018 | 54 | |
| 5 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Hit paper breakdown → | 2017 | 3855 |
| 6 | 2017 | 13 | |
| 7 | 2017 | 7 | |
| 8 | 2017 | 62 | |
| 9 | 2016 | 122 | |
| 10 | 2016 | 17 | |
| 11 | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Hit paper breakdown → | 2016 | 581 |
| 12 | 2016 | 161 | |
| 13 | 2016 | 175 | |
| 14 | 2015 | 145 | |
| 15 | 2015 | 74 | |
| 16 | 2015 | 1 | |
| 17 | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management Hit paper breakdown → | 2014 | 799 |
| 18 | 2013 | 25 | |
| 19 | Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence Hit paper breakdown → | 2012 | 651 |
| 20 | 2012 | 206 |
About Timothy Hardy
Timothy Hardy is a scholar working on Hepatology, Aging, Epidemiology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 23 papers that have together received 7.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (7 papers), Alcohol Consumption and Health Effects (6 papers), Liver Disease and Transplantation (3 papers), Liver physiology and pathology (3 papers), Epigenetics and DNA Methylation (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Organ Transplantation Techniques and Outcomes (2 papers). The work is most often cited by research in Hepatology (2.5k citations), Epidemiology (5.8k citations), Endocrinology, Diabetes and Metabolism (2.4k citations), Aging (134 citations) and Physiology (1.3k citations). Timothy Hardy has collaborated with scholars based in United Kingdom, Australia and Türkiye. Frequent co-authors include Quentin M. Anstee, Elisabetta Bugianesi, Jacob George, Mohammed Eslam, Zobair M. Younossi, Linda Henry, M. Marietti, Christopher P. Day, Stuart McPherson and Alastair D. Burt. Their work appears in journals such as Journal of Hepatology, Clinical Gastroenterology and Hepatology, Clinical Epigenetics, Gut and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.